| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/06/2005 | EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 04/06/2005 | EP1212100B1 Delivery system for antidandruff agent |
| 04/06/2005 | EP1179076B1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene |
| 04/06/2005 | EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2005 | EP1040182B1 Method for producing biomass by photosynthesis |
| 04/06/2005 | EP1003873B1 Increasing production of proteins in gram-positive microorganisms |
| 04/06/2005 | EP1002093B1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 04/06/2005 | EP0793727B1 Production of variant nisin |
| 04/06/2005 | EP0687144B2 Yeast-leavened refrigerated dough products |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |
| 04/06/2005 | CN1604964A Ashbya gossypii enzymes |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604907A Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus DNA polymerase I variants |
| 04/06/2005 | CN1604905A 重组牛凝血酶 Recombinant bovine thrombin |
| 04/06/2005 | CN1604741A Adhesion inhibition of moulds |
| 04/06/2005 | CN1603417A Human tyrosinase expression carrier and its use |
| 04/06/2005 | CN1603416A Recombinant monellin suitable to express in yeast and method for preparing same |
| 04/06/2005 | CN1603415A Fusion expression method of mycobacterium tuberculosis ESAT-6 protein in pichia |
| 04/06/2005 | CN1603403A Applied culture technology for salt tolerant rhodospirillum rubrum |
| 04/06/2005 | CN1603402A Method for preparing bifidobacterium lyophilized powder and its products and use |
| 04/06/2005 | CN1603401A Ganoderma lucidum mycelium with tea as matrix by double fermentation and its production method |
| 04/06/2005 | CN1603250A Biological treatment method for paper making black liquor |
| 04/06/2005 | CN1602708A Active bifidobacteria contained milk powder and its preparation method |
| 04/06/2005 | CN1195865C Method for eliminating CO2 poisoning in aerobic fermentation by using oxygen |
| 04/06/2005 | CN1195861C Encapsulation of polypeptides within starch matrix |
| 04/06/2005 | CN1195860C Delivery of biologically active polypeptides |
| 04/06/2005 | CN1195859C Modified human granulocyte-colony stimulating factor and process for producing same |
| 04/06/2005 | CN1195857C Multiply-substituted protease variants |
| 04/06/2005 | CN1195853C Neurotrophic factor NNT-1 |
| 04/06/2005 | CN1195849C APPIL-a novel protein with growth effects |
| 04/06/2005 | CN1195846C Peniophora phytase |
| 04/06/2005 | CN1195843C Solid culture method of antrodia camphorate, its cultured solid substance, and its product and application |
| 04/06/2005 | CN1195777C Novel insulin derivatives having rapid onset of action |
| 04/06/2005 | CN1195774C HEV antigenic peptide and its method |
| 04/06/2005 | CN1195530C Lactic acid bacteria strains capable of preventing diarrhea |
| 04/05/2005 | US6875845 Polypeptide for use in the treatment of cancer |
| 04/05/2005 | US6875606 Human α-7 nicotinic receptor promoter |
| 04/05/2005 | US6875601 Mutant Lactobacillus bulgaricus strains free from β-galactoside activity |
| 04/05/2005 | US6875599 Enzymatic protein for use in the treatment of inflammation, cancers, cardiovascular, brain, respiratory and crohn's disease |
| 04/05/2005 | US6875597 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 04/05/2005 | US6875592 Methods for the detection, analysis and isolation of nascent proteins |
| 04/05/2005 | US6875590 Nucleotide sequences coding polypeptide for use as tools in genetic engineering |
| 04/05/2005 | US6875589 Preparing mono-arginyl-insulin for treatment of diabetes; antidiabetic agents |
| 04/05/2005 | US6875588 Ovomucoid promoter and methods of use |
| 04/05/2005 | US6875586 Nucleotide sequences coding for the luxR gene |
| 04/05/2005 | US6875581 Identifying agonist and/or antagonist of calcium calmodulin-dependent protein kinases using laser fluctuation correlation spectroscopy; peptide mimetics; immunosuppressants |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | CA2203540C Major outer membrane protein cd of moraxella |
| 03/31/2005 | WO2005028665A2 Campylobacter polypeptides and methods of use |
| 03/31/2005 | WO2005028653A1 Method for neutralizing effects of secreted pla2 iia |
| 03/31/2005 | WO2005028646A1 Efficient method of preparing dna inverted repeat structure |
| 03/31/2005 | WO2005028637A1 Fungal hosts for expression of recombinant products |
| 03/31/2005 | WO2005028635A2 Microfluidic differential extraction cartridge |
| 03/31/2005 | WO2005028623A2 Broad host range pbbr1-based plasmid mutant derivatives having altered plasmid copy number |
| 03/31/2005 | WO2005028621A2 Assays with primary cells |
| 03/31/2005 | WO2005028515A1 Recombinant antibody against human insulin-like growth factor |
| 03/31/2005 | WO2005012533A3 Genotoxicity testing |
| 03/31/2005 | WO2005012495A3 Methods for expression and purification of immunotoxins |
| 03/31/2005 | WO2004092394A3 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof |
| 03/31/2005 | WO2004056965A3 Nucleic acids encoding antifungal drug targets and methods of use |
| 03/31/2005 | WO2004039234A3 Humanized antibodies against the venezuelan equine encephalitis virus |
| 03/31/2005 | WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2005 | WO2003018756A3 Methods for preparing purified prostaglandin e synthase |
| 03/31/2005 | US20050071890 Using vector transformation to generate cell comprising a nd expressing malarial merozoite surface protein (MSP-1) gene sequences; vaccine development and drug screening |
| 03/31/2005 | US20050070695 Expression vector comprising nucleotide sequences coding modified cholesterol binding toxin for use as tool in generating vaccine to prevent microorganismal infection; genetic vaccines; bactericides; immunotherapy |
| 03/31/2005 | US20050070692 Anti-interleukin-1 beta analogs |
| 03/31/2005 | US20050070691 Polypeptides of moraxella (branhamella) catarrhalis |
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050070435 encoding indole-3 acetic acid (IAA) production; Acinetobacter strains having the plasmid; a bioinoculum for promoting growth of wheat plant |
| 03/31/2005 | US20050070008 Method for the production of dinoflagellate cultures |
| 03/31/2005 | US20050070006 Method for detecting mutagenic substances |
| 03/31/2005 | US20050070005 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 03/31/2005 | US20050070004 Method for continuous culture of anaerobic bacterium |
| 03/31/2005 | US20050070003 Glucanase enzyme mixture for use in textile treatment and laundering detergents |
| 03/31/2005 | US20050070002 Histidine phosphatase interacting protein with 120kd |
| 03/31/2005 | US20050069996 Extracting reduced/oxidized forms via microbial cells |
| 03/31/2005 | US20050069995 (R)-hydroxycarboxylic acid producing recombinant microorganism and process for preparing (r)-hydroxycarboxylic acid using the same |
| 03/31/2005 | US20050069994 Nitrate reductase (NIR) defective escherichia for use in biosynthesis of arginine; bioreactors; supplements for medicine, animal feeds and cosmetics |
| 03/31/2005 | US20050069993 Fermentation, concentration; gene overexpression by increasing copy number or operably linking to promoter; quantitative analysis; isolation of L-threonine or L-lysine |
| 03/31/2005 | US20050069988 Recombinant expression systems for production of low solubility foreign proteins specifically aminoglobulin |
| 03/31/2005 | US20050069984 Identification of sortase gene |
| 03/31/2005 | US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders |
| 03/31/2005 | US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents |
| 03/31/2005 | US20050069975 Methods of enhancing yields of soluble proteins |
| 03/31/2005 | US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing |
| 03/31/2005 | US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 03/31/2005 | US20050069940 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 03/31/2005 | US20050069933 Transcritional replication enzyne for use in synthesizing RNA strands complementary to an RNA template; creating CDNA libraries |
| 03/31/2005 | US20050069908 DNA polymerase compositions for quantitative PCR and methods thereof |
| 03/31/2005 | US20050069896 Rb pathway and chromatin remodeling genes that antagonize let-60 Ras signaling |
| 03/31/2005 | US20050069894 Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation |
| 03/31/2005 | US20050069885 Transformed yeast comprising defective urea carboxylase-allophanate hydrolase gene and reduce nitrogen catabolite repression for use as tool in fermentation of alcoholic beverages |
| 03/31/2005 | US20050069883 Melanin-concentrating hormone receptor antagonist binding protein |
| 03/31/2005 | US20050069882 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation |
| 03/31/2005 | US20050069878 Proteins associated with cell growth, differentiation, and death |
| 03/31/2005 | US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | US20050069866 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/31/2005 | US20050069865 Synthetic hcv envelope proteins and their use for vaccination |